<DOC>
	<DOCNO>NCT02035748</DOCNO>
	<brief_summary>The purpose study observe anatomical functional outcome ocriplasmin ( JETREA® ) 6-month follow-up period .</brief_summary>
	<brief_title>Assessment Patients Treated With JETREA® Vitreomacular Traction</brief_title>
	<detailed_description>After receive single intravitreal injection per country 's product label ( Day 0 ) , subject follow 6-month period ( Day 180 ) .</detailed_description>
	<mesh_term>Tissue Adhesions</mesh_term>
	<criteria>Diagnosis vitreomacular traction/symptomatic vitreomacular adhesion ( VMT/sVMA ) , evidence focal VMA visible Spectral Domain Optical Coherence Tomography ( SDOCT ) . Read , sign , date Institutional Review Board/Ethics Committeeapproved inform consent form . Other protocoldefined inclusion criterion may apply . Women childbearing potential pregnant , breastfeeding , agreement use adequate birth control method prevent pregnancy throughout study . Hypersensitivity ocriplasmin JETREA® excipients . Active suspect intraocular periocular infection . Presence Epiretinal Membrane ( ERM ) macula baseline . Broad VMT/VMA &gt; 1500 micron baseline . History vitrectomy study eye . History laser photocoagulation macula study eye . Any relevant concomitant ocular condition , opinion investigator , could expect worsen require surgical intervention study period . Macular hole &gt; 400µm diameter study eye . High myopia study eye . Pseudoexfoliation , Marfan 's syndrome , phacodonesis find Investigator 's opinion suggest lens/zonular instability . Aphakia . History retinal detachment . Diabetic retinopathy , ischaemic retinopathy , retinal vein occlusion . Recent ocular surgery ocular injection . Vitreous hemorrhage . Exudative agerelated macular degeneration ( AMD ) . Therapy another investigational agent within 30 day prior Visit 1 . Active , simultaneous enrollment another ophthalmology clinical study . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Vitreomacular traction</keyword>
	<keyword>Symptomatic vitreomacular adhesion</keyword>
	<keyword>Ocriplasmin</keyword>
	<keyword>JETREA</keyword>
</DOC>